CONSENT Under the note purchase agreementNote Purchase Agreement • May 14th, 2013 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Michigan
This Consent (this “Consent”) under the Note Purchase Agreement (defined below) is effective as of the 1st day of April, 2013 by and between Interleukin Genetics, Inc. (“Borrower”) and Pyxis Innovations Inc. (“Lender”).
PREFERRED PARTICIPATION AGREEMENTPreferred Participation Agreement • May 14th, 2013 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Massachusetts
This PREFERRED PARTICIPATION AGREEMENT (this “Agreement”) is entered into as of February 25, 2013 (“Effective Date”), by and between Interleukin Genetics, Inc., a Delaware corporation with an address of 135 Beaver Street, Waltham, MA 02452, (“Interleukin”), and Renaissance Health Service Corporation and its affiliates and subsidiaries, with its principal place of business at 4100 Okemos Road, Okemos, Michigan 48864, (collectively, “RHSC”). Interleukin and RHSC may be referred to herein individually as a “Party” and collectively as the “Parties.”
